Perbedaan antara Jenis dan Derajat Kelainan Jantung serta Jenis Persalinan terhadap Outcome Ibu dan Bayi pada Kehamilan dengan Penyakit Jantung
Abstract
Abstrak
Tujuan: Penelitian ini dilakukan upaya untuk menilai karakteristik dan outcome kehamilan dengan kelainan jantung baik pada ibu dan bayi di RSUP dr. Hasan Sadikin Bandung dari tahun 2015 sampai 2017.
Metode: Penelitian ini merupakan penelitian observasional analitik (cross-sectional). Subjek penelitian adalah semua ibu hamil dengan kelainan jantung yang menjalani persalinan di RSUP dr. Hasan Sadikin Bandung dari tahun 2015 − 2017 dengan menggunakan data sekunder.
Hasil: Selama periode penelitian sebanyak 76 sampel penelitian yang diperoleh. Pada penelitian ini usia rata-rata ibu adalah 30 tahun, paling banyak pada paritas 1 dan 3 yaitu sebesar 31,6%. Usia kehamilan saat terjadi persalinan > 37 minggu sebanyak 53,9%. Lama perawatan pasien rata-rata 7 sampai 8 hari dengan ruang rawat yang paling banyak adalah ICU sebanyak 32,9%, dan ruang rawat biasa sebesar 39.5%. Jenis kelainan jantung yang paling sering adalah kardiomiopati peripartum dan hipertensi, yaitu sebesar 42,1%. Jenis persalinan yang banyak dilakukan adalah seksio sesarea yaitu sebesar 64,5%. Penelitian ini memperoleh bahwa ibu dengan kelainan jantung yang hidup sebesar 88,2% dan meninggal sebesar 11,8% setelah menjalani persalinan.
Kesimpulan: Ada perbedaan antara derajat kelainan jantung berdasarkan NYHA (New York Heart Association) dengan outcome ibu dan bayi pada kehamilan dengan kelainan jantung.
Differences between Types and Degrees of Heart Disorders and Types of Labor in the Outcome of Mothers and Babies in Pregnancy with Heart Disease
Abstract
Objective: through this research conducted efforts to assess the characteristics and outcome of pregnancy with cardiac disease both in mother and infant in dr dr. Hasan Sadikin Bandung from year 2015 to 2017.
Method: an observational analytic (cross-sectional) research with subjects were all pregnant women with cardiac abnormalities who underwent delivery at dr. Hasan Sadikin Bandung from 2015 to 2017 using secondary data.
Results:During the research period as many as 76 samples obtained. In this study the average age of the mother is 30 years, most at parity 1 and 3 that is equal to 31.6%, age of pregnancy during labor> 37 weeks by 53.9%. The average length of patient care was 7 to 8 days with the most hospital room was ICU of 32.9% and the regular room was 39.5%. The most common types of heart disorders are peripartum cardiomyopathy and hypertensive heart disease, which is 42.1%. Type of delivery mostly by cesarean section that is equal to 64.5%. The study found that mothers with heart abnormalities were 88.2% alive and died of 11.8% after going through labor.
Conclusion: There is a difference between the degree of cardiac abnormalities based on NYHA (New York Heart Association) classification with maternal and infant outcomes in pregnancy with cardiac abnormalities.
Key words: Type and Degree of Heart Abnormality, Type of Birth, Outcome of Mother and Infant
Keywords
Full Text:
PDFReferences
Simpson LL. Maternal cardiac disease: update for the clinician. Obstet Gynecol. 2012;119(2):345–59.
Lewis G. The Confidential Enquiry into Maternal and Child Health (CEMACH). Saving Mothers’ Lives: reviewing maternal deaths to make motherhood safer 2003–2005.
The Seventh Report of the Confidential Enquiries into Maternal Deaths in the UK. CEMACH. 2007;1(1):54.
Wilkinson H, Trustees, Advisers M. Saving mothers’ lives. Reviewing maternal deaths to make motherhood safer: 2006–2008.
The Eighth Report on Confidential Enquiries Into Maternal Death in United Kingdom. BJOG. 2011;118(11):1402–3.
Sarvasti D, Boestan I. Kehamilan dan Penyakit Jantung. In: Boestan I, editor. Penyakit Jantung & Kehamilan. Surabaya: Airlangga University Press; 2007. p. 30.
Elkayam U, Goland S, Pieper PG, Silversides CK. High-risk cardiac disease in pregnancy: Part II. J Am Coll Cardiol. 2016;68(5):502–16.
Thompson JL, Kuklina EV, Bateman BT, Callaghan WM, James AH, Grotegut CA. Medical and obstetric Outcomes among pregnant women with congenital heart disease. Obstet Gynecol. 2015;126(2):346.
Fretts RC, Schmittdiel J, McLean FH, Usher RH, Goldman MB. Increased maternal age and the risk of fetal death. N Engl J Med. 2005;333(15):953–7.
Cunningham FG, Leveno KJ. Childbearing among older women—the message is cautiously optimistic. N Engl J Med. 2005;333:1002.
Fett JD, Ansari AA, Sundstrom JB, Combs GF. Peripartum cardiomyopathy: a selenium disconnection and an autoimmune connection. Int J Cardiol. 2010;86(2):311–610.
Siu SC, Colman JM, Sorensen S, Smallhorn JF, Farine D, Amankwah KS, et al. Adverse neonatal and cardiac Outcomes are more common in pregnant women with cardiac disease. Circulation. 2010;105(18):2179–84.
Pearson GD, Veille J-C, Rahimtoola S, Hsia J, Oakley CM, Hosenpud JD, et al. Peripartum cardiomyopathy: national heart, lung, and blood institute and office of rare diseases (national institutes of health) workshop recommendations and review. JAMA. 2010;283(9):1183–8.
Elkayam U, Bitar F. Valvular heart disease and pregnancy: part II: prosthetic valves. J Am Coll Cardiol. 2005;46(3):403–10.
Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Drazner MH, et al. 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2013;128(16):1810–52.
European Society of Gynecology (ESG), Association for European Paediatric Cardiology (AEPC), German Society for Gender Medicine (DGesGM), Regitz-Zagrosek V, Blomstrom Lundqvist C, Borghi C, et al. ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J. 2011;32(24):3147–97.
Sliwa K, Hilfiker˗Kleiner D, Petrie MC, Mebazaa A, Pieske B, Buchmann E, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur J Heart Fail. 2010;12(8):767–78.
Magee LA, Pels A, Helewa M, Rey E, von Dadelszen P, Audibert F, et al. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy: executive summary. J Obstet Gynaecol Can. 2014;36(5):416–38.
Siu SC, Sermer M, Colman JM, Alvarez AN, Mercier L-A, Morton BC, et al. Prospective multicenter study of pregnancy Outcomes in women with heart disease. Circulation. 2011;104(5):515–21.
Thorne S. Pregnancy in heart disease. Heart. 2014;90(4):450–6.
Robson S, Dunlop W, Moore M, Hunter S. Haemodynamic changes during the puerperium: a Doppler and M˗mode echocardiographic study. Br J Obstet Gynaecol. 2007;94(11):1028–39.
Metcalfe J, Ueland K. Maternal cardiovascular adjustments to pregnancy. Prog Cardiovasc. 2007;16(4):363–74.
Elkayam U, Gleicher N. Hemodynamics and cardiac function during normal pregnancy and the puerperium. In: Elkayam U, Gleicher N, editors. Cardiac Problems in Pregnancy. 2nd ed. New York: Liss; 2000. p. 5–24.
Bonow RO, Carabello BA, Chatterjee K, de Leon AC, Faxon DP, Freed MD, et al. ACC/AHA 2006 practice guidelines for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol. 2010;48(3):598–675.
DOI: http://dx.doi.org/10.24198/obgynia.v2i1.87
Refbacks
- There are currently no refbacks.
_CROSREF22.jpg)
